Is PeterMd legit and worth it?
PeterMd is a real GLP-1 telehealth provider; we read its site and scored it 2.5/5 in our independent review (High Caution). Biggest plus: Pricing: $149 - $249/mo. Watch-out: No/minimal Trustpilot reviews.
Scorecard: strongest in Access (4.7/5) and Cost & Value (3.6/5); weakest in Reputation (1.2/5) and Trust & Transparency (1.8/5).
Medications
Compounded, Tirzepatide (as entered 10 April 2026; capture date not recorded)
Monthly Cost
$149 – $249/mo (as entered 10 April 2026; capture date not recorded)
Speed to Start
Fast
Trustpilot
Not yet rated (as recorded April 2026; not re-checked)
Prices and medications in this review are as entered in our research on 10 April 2026 (the date we captured them was not recorded), unless a line is marked otherwise, and have not been re-checked since. Note added 13 October 2026.
Corrected 14 October 2026: this review previously gave a Better Business Bureau rating or listing status. We kept no record of where it came from, so it has been removed. Trustpilot figures in this review are as recorded in April 2026 and have not been re-checked.
Est. 2021
About PeterMd
PeterMd has been operating since 2021, making it one of the longer-tenured providers in the compounded GLP-1 space. The platform focuses exclusively on compounded tirzepatide, with pricing between $149 and $249 per month — a competitive range for this medication class. However, the concerning signals surrounding this provider far outweigh its pricing advantage, and our editorial team has significant reservations about recommending PeterMd to readers.
The most alarming finding in our research is that PeterMd’s Trustpilot page has been removed. While there can be legitimate reasons for a Trustpilot page disappearing, in our experience reviewing dozens of telehealth providers, a removed review page is a serious red flag. It often indicates that the volume or nature of complaints triggered Trustpilot’s fraud detection systems, or that the company itself requested removal to hide negative feedback. Either scenario should give prospective patients pause.
Our research notes reference “questionable practices” associated with this provider, though specific details are difficult to verify given the limited public information available. A removed Trustpilot page creates a trust profile that is among the worst we have encountered in our reviews.
From a clinical perspective, PeterMd does not offer lab testing or dietitian support, and the quality of its medical providers has been flagged as low in our assessment. Without lab work, there is no mechanism to establish baseline health markers or monitor patients for potential side effects related to tirzepatide therapy. The narrow medication focus — only compounded tirzepatide — also limits options for patients who might benefit from semaglutide-based treatments instead.
Despite its relatively affordable pricing, PeterMd represents one of the higher-risk choices in the GLP-1 telehealth market. The convergence of a removed review platform and reports of questionable practices paints a troubling picture. Our editorial team strongly advises prospective patients to exercise extreme caution and consider providers with transparent, verifiable track records before entrusting their health — and their money — to this platform.
PeterMd GLP-1 Medications
Screenshot of PeterMd, captured by 10 April 2026
Screenshot of PeterMd, captured by 10 April 2026
Screenshot of PeterMd, captured by 10 April 2026
Screenshot of PeterMd, captured by 10 April 2026
Screenshot of PeterMd, captured by 10 April 2026
At a Glance
Medications Offered
Compounded, Tirzepatide (as entered 10 April 2026; capture date not recorded)
Compounded
Cost & Insurance
- Monthly: $149 – $249/mo (as entered 10 April 2026; capture date not recorded)
- 6-month estimate: $899 – $1400 (as entered 10 April 2026; capture date not recorded)
- Insurance: No
- Self-pay: Yes
Clinical Features
- Lab testing: No
- Dietitian access: No
- Pharmacies named: Not disclosed; F BBB; Trustpilot page removed
Delivery & Access
- Format: Subcutaneous
- Nationwide telehealth: Yes
- Speed: Fast
- Spanish-speaking providers: Not stated Corrected 13 October 2026: this line said “Not available”, but our research had recorded it as unknown.
How GLP-1 Access Works at PeterMD
PeterMD is structured as a shop / e-commerce checkout, not a clinical questionnaire. The path is product page → Add to Cart → checkout → pay. The platform positions itself as “America’s Most Trusted Men’s Health Clinic” and lists Tirzepatide alongside testosterone, sexual function, hair loss, and longevity products in a unified men’s-health catalog.
There is no clinical intake in the visible flow — no health history, no contraindication check, no BMI, no medication review. Per the checkout disclaimer: “All prescription medications require approval from a licensed healthcare provider following a virtual consultation. Purchasing a product does not guarantee eligibility. If a prescription is not approved, the order will be canceled, and a full refund will be issued.” In other words, the patient pays first, then a virtual consultation determines whether the order ships. Whatever clinical screening exists happens post-payment and is not observable to a prospective patient evaluating the platform.
What the PeterMD Checkout Looks Like
Because PeterMD doesn’t run a clinical intake, our usual clinical-rigor and friction scoring doesn’t apply. Instead, here’s a plain walkthrough of the five screens between the Tirzepatide product page and the “Complete Purchase” button.
The 3 Stages
This is not a clinical intake. There are no health questions, no contraindication checks (MTC, MEN2, pancreatitis, T1D, pregnancy), no medication review, no allergy screen, no BMI calculation, no labs, no eating-disorder or substance-use screen, no PHQ, and no clinician review at any visible step. The flow’s only purpose is to capture customer information and a payment for the Tirzepatide product. Clinical responsibility — including any safety screening that exists — happens after payment in a virtual consultation that is invisible to a prospective patient evaluating the platform.
PeterMD’s checkout collects payment before any clinical screening. The footer disclaimer is explicit: “Purchasing a product does not guarantee eligibility. If a prescription is not approved, the order will be canceled, and a full refund will be issued.” Patients pay $672.82 today (a $647 quarterly Tirzepatide supply plus a $25.82 service fee), then enter a virtual consultation that determines whether the medication actually ships. The refund policy mitigates the financial risk, but patients should understand that the clinical screening they typically expect to see in an online intake — health history, contraindications, allergies, current medications — happens only after they have committed payment.
Source: GLP-1.Reviews editorial walkthrough on April 30, 2026. We completed every observable screen of the PeterMD Tirzepatide flow and stopped before submitting payment information. No clinical scoring is published for PeterMD because the pay-first / clinical-after model does not include a pre-payment clinical intake.
Start your GLP-1 weight loss journey with PeterMd today
Medical Disclaimer: This review is for informational purposes only and does not constitute medical advice. GLP-1 medications are prescription drugs that should only be used under the supervision of a licensed healthcare provider. Individual results may vary.
Editorial Independence: GLP-1.Reviews maintains full editorial independence. We read providers’ own pages and public records and publish what we find, with the date we checked.
Corrected 13 October 2026: this review showed a “Verified Provider” badge and said our scores were “based on verified data and standardized criteria”. Neither described a check we had done, so both have been removed.
